Zurich weekly markets updates
Investment Categories
Latest weekly investment articles
There was an optimistic start to the week, as the FDA in the US announced full approval for the Pfizer vaccine which could see a wider take up which in turn would help contribute to economic activity, writes Ian Slattery.
Equities hit record highs on Monday, before sliding over the course of the rest of the week, writes Ian Slattery.
Stocks moved forward once again in a light week for economic data, with the summer holiday season taking hold. However, the US data that was released was taken positively, writes Ian Slattery.
US markets hit record highs last week with strong earnings and a positive jobs report the main drivers, writes Ian Slattery.
Major indexes finished the week lower, as a pullback towards the end of the week dragged them off record highs, writes Ian Slattery.
Stocks fell sharply on Monday last week as concerns over the COVID-19 Delta variant rose to the surface, writes Ian Slattery.
Global equity returns were negative last week with inflation likely to be the main topic of conversation for the rest of the year, writes Ian Slattery.
There was little economic news in a holiday shortened week for the US market. However, this left somewhat of a vacuum for markets to focus on a rise in COVID-19 numbers on the back of new variants, writes Ian Slattery.
Markets moved higher again last week amid relatively benign volatility conditions, writes Ian Slattery.
Despite it being a relatively light week for new economic data, the S&P 500 made a significant move on Thursday, writes Ian Slattery.